Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Oligonucleotide Therapy-based Drug
1.2 Key Market Segments
1.2.1 Oligonucleotide Therapy-based Drug Segment by Type
1.2.2 Oligonucleotide Therapy-based Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Oligonucleotide Therapy-based Drug Market Overview
2.1 Global Market Overview
2.1.1 Global Oligonucleotide Therapy-based Drug Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Oligonucleotide Therapy-based Drug Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Oligonucleotide Therapy-based Drug Market Competitive Landscape
3.1 Global Oligonucleotide Therapy-based Drug Sales by Manufacturers (2019-2025)
3.2 Global Oligonucleotide Therapy-based Drug Revenue Market Share by Manufacturers (2019-2025)
3.3 Oligonucleotide Therapy-based Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Oligonucleotide Therapy-based Drug Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Oligonucleotide Therapy-based Drug Sales Sites, Area Served, Product Type
3.6 Oligonucleotide Therapy-based Drug Market Competitive Situation and Trends
3.6.1 Oligonucleotide Therapy-based Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Oligonucleotide Therapy-based Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Oligonucleotide Therapy-based Drug Industry Chain Analysis
4.1 Oligonucleotide Therapy-based Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Oligonucleotide Therapy-based Drug Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Oligonucleotide Therapy-based Drug Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oligonucleotide Therapy-based Drug Sales Market Share by Type (2019-2025)
6.3 Global Oligonucleotide Therapy-based Drug Market Size Market Share by Type (2019-2025)
6.4 Global Oligonucleotide Therapy-based Drug Price by Type (2019-2025)
7 Oligonucleotide Therapy-based Drug Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oligonucleotide Therapy-based Drug Market Sales by Application (2019-2025)
7.3 Global Oligonucleotide Therapy-based Drug Market Size (M USD) by Application (2019-2025)
7.4 Global Oligonucleotide Therapy-based Drug Sales Growth Rate by Application (2019-2025)
8 Oligonucleotide Therapy-based Drug Market Consumption by Region
8.1 Global Oligonucleotide Therapy-based Drug Sales by Region
8.1.1 Global Oligonucleotide Therapy-based Drug Sales by Region
8.1.2 Global Oligonucleotide Therapy-based Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Oligonucleotide Therapy-based Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Oligonucleotide Therapy-based Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Oligonucleotide Therapy-based Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Oligonucleotide Therapy-based Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Oligonucleotide Therapy-based Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Oligonucleotide Therapy-based Drug Market Production by Region
9.1 Global Production of Oligonucleotide Therapy-based Drug by Region (2019-2025)
9.2 Global Oligonucleotide Therapy-based Drug Revenue Market Share by Region (2019-2025)
9.3 Global Oligonucleotide Therapy-based Drug Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Oligonucleotide Therapy-based Drug Production
9.4.1 North America Oligonucleotide Therapy-based Drug Production Growth Rate (2019-2025)
9.4.2 North America Oligonucleotide Therapy-based Drug Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Oligonucleotide Therapy-based Drug Production
9.5.1 Europe Oligonucleotide Therapy-based Drug Production Growth Rate (2019-2025)
9.5.2 Europe Oligonucleotide Therapy-based Drug Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Oligonucleotide Therapy-based Drug Production (2019-2025)
9.6.1 Japan Oligonucleotide Therapy-based Drug Production Growth Rate (2019-2025)
9.6.2 Japan Oligonucleotide Therapy-based Drug Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Oligonucleotide Therapy-based Drug Production (2019-2025)
9.7.1 China Oligonucleotide Therapy-based Drug Production Growth Rate (2019-2025)
9.7.2 China Oligonucleotide Therapy-based Drug Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Sarepta Therapeutics
10.1.1 Sarepta Therapeutics Oligonucleotide Therapy-based Drug Basic Information
10.1.2 Sarepta Therapeutics Oligonucleotide Therapy-based Drug Product Overview
10.1.3 Sarepta Therapeutics Oligonucleotide Therapy-based Drug Product Market Performance
10.1.4 Sarepta Therapeutics Business Overview
10.1.5 Sarepta Therapeutics Oligonucleotide Therapy-based Drug SWOT Analysis
10.1.6 Sarepta Therapeutics Recent Developments
10.2 Ionis Pharmaceuticals
10.2.1 Ionis Pharmaceuticals Oligonucleotide Therapy-based Drug Basic Information
10.2.2 Ionis Pharmaceuticals Oligonucleotide Therapy-based Drug Product Overview
10.2.3 Ionis Pharmaceuticals Oligonucleotide Therapy-based Drug Product Market Performance
10.2.4 Ionis Pharmaceuticals Business Overview
10.2.5 Ionis Pharmaceuticals Oligonucleotide Therapy-based Drug SWOT Analysis
10.2.6 Ionis Pharmaceuticals Recent Developments
10.3 Alnylam
10.3.1 Alnylam Oligonucleotide Therapy-based Drug Basic Information
10.3.2 Alnylam Oligonucleotide Therapy-based Drug Product Overview
10.3.3 Alnylam Oligonucleotide Therapy-based Drug Product Market Performance
10.3.4 Alnylam Oligonucleotide Therapy-based Drug SWOT Analysis
10.3.5 Alnylam Business Overview
10.3.6 Alnylam Recent Developments
10.4 Biogen
10.4.1 Biogen Oligonucleotide Therapy-based Drug Basic Information
10.4.2 Biogen Oligonucleotide Therapy-based Drug Product Overview
10.4.3 Biogen Oligonucleotide Therapy-based Drug Product Market Performance
10.4.4 Biogen Business Overview
10.4.5 Biogen Recent Developments
10.5 Nippon Shinyaku
10.5.1 Nippon Shinyaku Oligonucleotide Therapy-based Drug Basic Information
10.5.2 Nippon Shinyaku Oligonucleotide Therapy-based Drug Product Overview
10.5.3 Nippon Shinyaku Oligonucleotide Therapy-based Drug Product Market Performance
10.5.4 Nippon Shinyaku Business Overview
10.5.5 Nippon Shinyaku Recent Developments
10.6 Sobi
10.6.1 Sobi Oligonucleotide Therapy-based Drug Basic Information
10.6.2 Sobi Oligonucleotide Therapy-based Drug Product Overview
10.6.3 Sobi Oligonucleotide Therapy-based Drug Product Market Performance
10.6.4 Sobi Business Overview
10.6.5 Sobi Recent Developments
10.7 Novartis
10.7.1 Novartis Oligonucleotide Therapy-based Drug Basic Information
10.7.2 Novartis Oligonucleotide Therapy-based Drug Product Overview
10.7.3 Novartis Oligonucleotide Therapy-based Drug Product Market Performance
10.7.4 Novartis Business Overview
10.7.5 Novartis Recent Developments
10.8 BioNTech
10.8.1 BioNTech Oligonucleotide Therapy-based Drug Basic Information
10.8.2 BioNTech Oligonucleotide Therapy-based Drug Product Overview
10.8.3 BioNTech Oligonucleotide Therapy-based Drug Product Market Performance
10.8.4 BioNTech Business Overview
10.8.5 BioNTech Recent Developments
10.9 Pfizer
10.9.1 Pfizer Oligonucleotide Therapy-based Drug Basic Information
10.9.2 Pfizer Oligonucleotide Therapy-based Drug Product Overview
10.9.3 Pfizer Oligonucleotide Therapy-based Drug Product Market Performance
10.9.4 Pfizer Business Overview
10.9.5 Pfizer Recent Developments
10.10 Moderna Therapeutics
10.10.1 Moderna Therapeutics Oligonucleotide Therapy-based Drug Basic Information
10.10.2 Moderna Therapeutics Oligonucleotide Therapy-based Drug Product Overview
10.10.3 Moderna Therapeutics Oligonucleotide Therapy-based Drug Product Market Performance
10.10.4 Moderna Therapeutics Business Overview
10.10.5 Moderna Therapeutics Recent Developments
10.11 Jazz Pharmaceuticals
10.11.1 Jazz Pharmaceuticals Oligonucleotide Therapy-based Drug Basic Information
10.11.2 Jazz Pharmaceuticals Oligonucleotide Therapy-based Drug Product Overview
10.11.3 Jazz Pharmaceuticals Oligonucleotide Therapy-based Drug Product Market Performance
10.11.4 Jazz Pharmaceuticals Business Overview
10.11.5 Jazz Pharmaceuticals Recent Developments
10.12 CureVac
10.12.1 CureVac Oligonucleotide Therapy-based Drug Basic Information
10.12.2 CureVac Oligonucleotide Therapy-based Drug Product Overview
10.12.3 CureVac Oligonucleotide Therapy-based Drug Product Market Performance
10.12.4 CureVac Business Overview
10.12.5 CureVac Recent Developments
10.13 Regulus Therapeutics
10.13.1 Regulus Therapeutics Oligonucleotide Therapy-based Drug Basic Information
10.13.2 Regulus Therapeutics Oligonucleotide Therapy-based Drug Product Overview
10.13.3 Regulus Therapeutics Oligonucleotide Therapy-based Drug Product Market Performance
10.13.4 Regulus Therapeutics Business Overview
10.13.5 Regulus Therapeutics Recent Developments
10.14 ProQR
10.14.1 ProQR Oligonucleotide Therapy-based Drug Basic Information
10.14.2 ProQR Oligonucleotide Therapy-based Drug Product Overview
10.14.3 ProQR Oligonucleotide Therapy-based Drug Product Market Performance
10.14.4 ProQR Business Overview
10.14.5 ProQR Recent Developments
10.15 Secarna
10.15.1 Secarna Oligonucleotide Therapy-based Drug Basic Information
10.15.2 Secarna Oligonucleotide Therapy-based Drug Product Overview
10.15.3 Secarna Oligonucleotide Therapy-based Drug Product Market Performance
10.15.4 Secarna Business Overview
10.15.5 Secarna Recent Developments
10.16 MiNA Therapeutics
10.16.1 MiNA Therapeutics Oligonucleotide Therapy-based Drug Basic Information
10.16.2 MiNA Therapeutics Oligonucleotide Therapy-based Drug Product Overview
10.16.3 MiNA Therapeutics Oligonucleotide Therapy-based Drug Product Market Performance
10.16.4 MiNA Therapeutics Business Overview
10.16.5 MiNA Therapeutics Recent Developments
10.17 Sylentis
10.17.1 Sylentis Oligonucleotide Therapy-based Drug Basic Information
10.17.2 Sylentis Oligonucleotide Therapy-based Drug Product Overview
10.17.3 Sylentis Oligonucleotide Therapy-based Drug Product Market Performance
10.17.4 Sylentis Business Overview
10.17.5 Sylentis Recent Developments
10.18 Arrowhead
10.18.1 Arrowhead Oligonucleotide Therapy-based Drug Basic Information
10.18.2 Arrowhead Oligonucleotide Therapy-based Drug Product Overview
10.18.3 Arrowhead Oligonucleotide Therapy-based Drug Product Market Performance
10.18.4 Arrowhead Business Overview
10.18.5 Arrowhead Recent Developments
10.19 Silence Therapeutics
10.19.1 Silence Therapeutics Oligonucleotide Therapy-based Drug Basic Information
10.19.2 Silence Therapeutics Oligonucleotide Therapy-based Drug Product Overview
10.19.3 Silence Therapeutics Oligonucleotide Therapy-based Drug Product Market Performance
10.19.4 Silence Therapeutics Business Overview
10.19.5 Silence Therapeutics Recent Developments
10.20 Dicerna
10.20.1 Dicerna Oligonucleotide Therapy-based Drug Basic Information
10.20.2 Dicerna Oligonucleotide Therapy-based Drug Product Overview
10.20.3 Dicerna Oligonucleotide Therapy-based Drug Product Market Performance
10.20.4 Dicerna Business Overview
10.20.5 Dicerna Recent Developments
11 Oligonucleotide Therapy-based Drug Market Forecast by Region
11.1 Global Oligonucleotide Therapy-based Drug Market Size Forecast
11.2 Global Oligonucleotide Therapy-based Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Oligonucleotide Therapy-based Drug Market Size Forecast by Country
11.2.3 Asia Pacific Oligonucleotide Therapy-based Drug Market Size Forecast by Region
11.2.4 South America Oligonucleotide Therapy-based Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Oligonucleotide Therapy-based Drug by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Oligonucleotide Therapy-based Drug Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Oligonucleotide Therapy-based Drug by Type (2025-2032)
12.1.2 Global Oligonucleotide Therapy-based Drug Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Oligonucleotide Therapy-based Drug by Type (2025-2032)
12.2 Global Oligonucleotide Therapy-based Drug Market Forecast by Application (2025-2032)
12.2.1 Global Oligonucleotide Therapy-based Drug Sales (K MT) Forecast by Application
12.2.2 Global Oligonucleotide Therapy-based Drug Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
